Data capture is no longer the bottleneck, and whether the lag between a signal and a decision shrinks depends on signal design, AI governance, and vendor orchestration.
|Webcasts|November 2, 2021
Making Every Connection Count- IQVIA Connected Devices powers clinical trials with better data
Author(s)IQVIA
Tuesday, November 2, 2021 at 11am EDT Get treatments to patients faster and deliver a better experience for both patients and clinical trial sites. Join IQVIA leaders Jeff Noll and Sara Pawley and learn how IQVIA matches the right connected device for each study protocol to enhance data quality, speed data collection, and accelerate trial outcomes.
Register free:
Event Overview:
As clinical trial sponsors face increasing pressure to deliver new treatments to market faster, connected digital medical devices are taking on a larger and more critical role.
In this webinar, Connected Devices leaders Jeff Noll and Sara Pawley from IQVIA will discuss how to simplify and accelerate data collection for your clinical trials with expert medical device selection and a smart data strategy.
In addition to showing you how to gain a digital advantage, this webinar highlights the importance of (and the challenges behind) choosing the right device for your study protocols. You’ll also learn how those choices, and the connections they enable, are key to making participation for patients easier and the resulting data more trustworthy and timely. Join us for this important webinar and explore the advantages of using an advanced data platform to aggregate and clean patient data to accelerate insights. Discover the role expert guidance and support can play in reducing the logistical burdens of adopting a digital-first approach to patient data collection.
3 Key Take-aways:
- IQVIA Connected Devices-
- Better devices—for your study protocol and endpoint strategy
- Better data—streamlined collection and compliant reporting
- Better solutions—flexible service and support options to match your needs and priorities
Speakers
Jeffrey Noll
Global Head, Connected Devices
IQVIA
Sara Pawley
Connected Devices Strategic Solutions
IQVIA
Sponsor:
IQVIA
Register free:
Related to this article
In this Q&A, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, discusses what changes when AI is embedded across protocol strategy, data infrastructure, and workflow tools at once, where governance frameworks tend to fall short, and why CROs must orchestrate AI ecosystems rather than simply aggregate them.
In today’s ACT Brief, we examine what policy changes would help community and rural institutions join research, how Walmart is expanding clinical trial centers into three more states, and how FDA approved Ilumya for adults with active psoriatic arthritis.
The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health screenings inside Walmart stores.
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.
In today’s ACT Brief, we examine why community and rural patients lack access to research as a care option, what makes AI assistants trustworthy in regulated trials, and how FDA draft guidance could let gene editing therapies cover patient-specific variants.
In this Q&A, E.K. Koh, chief product officer at Suvoda, discusses what separates a trustworthy AI assistant from one that adds risk, why curated clinical knowledge matters more than general-purpose flexibility, and what safeguards must be in place when assistants move from answering questions to taking actions in clinical trial systems.
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patients in community and rural settings too often lack access to clinical research as a care option, and how closing that gap could improve outcomes and lower long-term costs.
Trending on Applied Clinical Trials Online
1
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
2
What Needs to Happen Beyond the Clinical Trial Modernization Act
3
From Signal to Action: Why Faster Trial Data Isn’t Producing Faster Decisions
4
Walmart and Care Access Plan Three More Clinical Trial Centers in Michigan, Nevada, and Texas
5